Browsing Category

63265 posts
First Patient Dosed in Clinical Trial of YOLT-201 for the Treatment of Hereditary ATTR-CM

First Patient Dosed in Clinical Trial of YOLT-201 for the Treatment of Hereditary ATTR-CM

SHANGHAI, Dec. 17, 2023 /PRNewswire/ — YolTech Therapeutics today announced that the…
VRITIMES Philippines Now Featured on Google News

VRITIMES Philippines Now Featured on Google News

Manila, 11/Dec/2023 – VRITIMES Philippines, a pioneering media technology startup established in…
VESSEL HEALTH & CONDITION MONITORING, PREDICTIVE MAINTENANCE & DIAGNOSTICS

VESSEL HEALTH & CONDITION MONITORING, PREDICTIVE MAINTENANCE & DIAGNOSTICS

Optimizing Machinery Performance, Energy Efficiency, Vessel Performance with Integrated Digital Platform and…
COSRX Introduces The Retinol 0.3 Cream, a Breakthrough in Anti-Aging Skincare

COSRX Introduces The Retinol 0.3 Cream, a Breakthrough in Anti-Aging Skincare

Launching a 3x more powerful pure Retinol 0.3% solution for more effective…
Outlook Quarter 4/2023

Outlook Quarter 4/2023

SCB EIC revised down 2023 growth forecast to 2.6% due to Q3 GDP, government spending, and lower tourist arrivals. 2024 economy to grow at 3.0% with expanding exports and private investment. Concerns about slow recovery, inflation, and global economy. Long-term issues include low investment and slow revenue recovery. Solutions proposed to address structural issues.
Allins Unveils Its Plan to Set New Inscription Trading Standards for Enhanced Multi-Chain Experience

Allins Unveils Its Plan to Set New Inscription Trading Standards for Enhanced Multi-Chain Experience

Multi-Chain Inscription AMM, Allins Opens A New Era for Inscription Trading, First…